San Mateo, CA, United States of America

Daniel David Kaplan

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Daniel David Kaplan

Introduction

Daniel David Kaplan is a prominent inventor based in San Mateo, California. He has made significant contributions to the field of biopharmaceuticals, holding a total of eight patents. His work focuses on developing binding agents that have important applications in medical science.

Latest Patents

Kaplan's latest patents include innovative binding agents and methods of use thereof. One of his notable patents involves ILT-binding agents that specifically bind ILT2, ILT4, or both. This patent provides compositions comprising these binding agents and outlines methods for their use. Additionally, he has developed ILT3-binding agents that specifically bind ILT3, including human ILT3. This patent also includes related polynucleotides and vectors encoding the binding agents, as well as cells that comprise these agents.

Career Highlights

Kaplan is currently associated with Ngm Biopharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in the creation of novel therapeutic agents that have the potential to impact patient care significantly.

Collaborations

Some of his notable coworkers include Yan Wang and Dana Yen Mei Duey. Their collaborative efforts contribute to the innovative environment at Ngm Biopharmaceuticals, Inc.

Conclusion

Daniel David Kaplan is a key figure in the biopharmaceutical industry, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new treatments and therapies that could benefit many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…